Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Hooper

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Clinical Pharmacology and Therapeutics|April 1, 1975
Plasma protein binding of carbamazepineW D Hooper, D K Dubetz, F Bochner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formationL Cuttle, A J Munns, N A Hogg, et al.
Toxicology and Applied Pharmacology|April 1, 1973
Possible acute liver toxicity from the hypolipidemic agent 1-methyl-4-piperidyl-bis(p-chlorophenoxy)-acetateF Bochner, B E Cham, M J Eadie, et al.
Archives of Biochemistry and Biophysics|March 10, 1995
Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5' modification, purification, spectral characterization, reconstitution conditions, and catalytic activitiesE M Gillam, Z Guo, Y F Ueng, et al.
Epilepsy Research|August 30, 2000
Valproate metabolism during valproate-associated hepatotoxicity in a surviving adult patientD B McLaughlin, M J Eadie, S L Parker-Scott, et al.
Epilepsia|January 1, 1996
Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidationW D Hooper, M E Franklin, P Glue, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Clinical Pharmacology and Therapeutics|April 1, 1975
Plasma protein binding of carbamazepineW D Hooper, D K Dubetz, F Bochner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formationL Cuttle, A J Munns, N A Hogg, et al.
Toxicology and Applied Pharmacology|April 1, 1973
Possible acute liver toxicity from the hypolipidemic agent 1-methyl-4-piperidyl-bis(p-chlorophenoxy)-acetateF Bochner, B E Cham, M J Eadie, et al.
Archives of Biochemistry and Biophysics|March 10, 1995
Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5' modification, purification, spectral characterization, reconstitution conditions, and catalytic activitiesE M Gillam, Z Guo, Y F Ueng, et al.
Epilepsy Research|August 30, 2000
Valproate metabolism during valproate-associated hepatotoxicity in a surviving adult patientD B McLaughlin, M J Eadie, S L Parker-Scott, et al.
Epilepsia|January 1, 1996
Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidationW D Hooper, M E Franklin, P Glue, et al.
Pageof 11